Neuphoria Therapeutics Inc. (NEUP)

NGM – Real Time Price. Currency in USD

4.93

-0.25 (-4.73%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

16M

191K

Cost of goods sold

-663K

-446K

Gross Profit

15M

-663K

-446K

Operating expenses (excl. COGS)

-16M

-17M

-14M

-19M

Operating Income

-1M

-18M

-15M

-20M

Non-operating income, total

291K

-442K

Pretax income

-838K

-16M

-15M

-20M

Equity in earnings

Taxes

468K

87K

378K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-370K

-15M

-14M

-16M

Neuphoria Therapeutics Inc. (NEUP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Neuphoria Therapeutics Inc. (NEUP)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Neuphoria Therapeutics Inc. (NEUP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Neuphoria Therapeutics Inc. (NEUP)

Income Statement (Annual)

Income Statement (Annual)